Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-09-2011 | Article

Assessment of the presence of extended-spectrum beta-lactamase-producing Escherichia coli in eggshells and ready-to-eat products

Authors: P. Egea, L. López-Cerero, M. D. Navarro, J. Rodríguez-Baño, A. Pascual

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2011

Abstract

The principal objective of this study was to assess whether chicken eggshells may be contaminated by ESBL-producing E. coli (ESBLC). Additional analyses were carried out to determine if ESBLEC could be detected in other foodstuffs such as cooked poultry or fresh vegetables. Seventy-two eggshells from different supermarkets and stores as well as 32 salads, 30 samples of cooked poultry and six samples of chicken-based pet food samples were analysed. Characterization of ESBL was performed by PCR and sequencing. Antimicrobial resistance was determined by disk diffusion method. Phylogenetic group was assigned by multiplex-PCR. No ESBLEC was isolated from chicken eggshells, cooked chicken and pet food. One SHV-12-producing E. coli was isolated from a salad sample. This is the first study to analyse chicken eggs in an area where there is a high prevalence of ESBLEC in retail chicken meat.

Blanc V, Mesa R, Saco M, Lavilla S, Prats G, Miro E, Navarro F, Cortes P, Llagostera M (2006) ESBL- and plasmidic class C beta-lactamase-producing E. coli strains isolated from poultry, pig and rabbit farms. Vet Microbiol 118:299–304PubMedCrossRef

Bortolaia V, Guardabassi L, Bisgaard M, Larsen J, Bojesen AM (2010) Escherichia coli producing CTX-M-1, -2, and -9 group beta-lactamases in organic chicken egg production. Antimicrob Agents Chemother 54:3527–3528PubMedCrossRef

Brinas L, Moreno MA, Zarazaga M, Porrero C, Saenz Y, Garcia M, Dominguez L, Torres C (2003) Detection of CMY-2, CTX-M-14, and SHV-12 beta-lactamases in Escherichia coli fecal-sample isolates from healthy chickens. Antimicrob Agents Chemother 47:2056–2058PubMedCrossRef

Carattoli A, Lovari S, Franco A, Cordaro G, Di Matteo P, Battisti A (2005) Extended-spectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob Agents Chemother 49:833–835PubMedCrossRef

Chavez C, Knape KD, Coufal CD, Carey JB (2002) Reduction of eggshell aerobic plate counts by ultraviolet irradiation. Poult Sci 81:1132–1135PubMed

Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555–4558PubMedCrossRef

Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing: 19th informational supplement. M100-S19. CLSI, Wayne, PA

Costa D, Poeta P, Brinas L, Saenz Y, Rodrigues J, Torres C (2004) Detection of CTX-M-1 and TEM-52 beta-lactamases in Escherichia coli strains from healthy pets in Portugal. J Antimicrob Chemother 54:960–961PubMedCrossRef

Doi Y, Paterson DL, Egea P, Pascual A, Lopez-Cerero L, Navarro MD, Adams-Haduch JM, Qureshi ZA, Sidjabat HE, Rodriguez-Bano J (2010) Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect 16:33–38PubMedCrossRef

10.

Duan RS, Sit TH, Wong SS, Wong RC, Chow KH, Mak GC, Yam WC, Ng LT, Yuen KY, Ho PL (2006) Escherichia coli producing CTX-M beta-lactamases in food animals in Hong Kong. Microb Drug Resist 12:145–148PubMedCrossRef

11.

Huneau-Salaun A, Michel V, Huonnic D, Balaine L, Le Bouquin S (2010) Factors influencing bacterial eggshell contamination in conventional cages, furnished cages and free-range systems for laying hens under commercial conditions. Br Poult Sci 51:163–169PubMedCrossRef

12.

Jensen LB, Hasman H, Agerso Y, Emborg HD, Aarestrup FM (2006) First description of an oxyimino-cephalosporin-resistant, ESBL-carrying Escherichia coli isolated from meat sold in Denmark. J Antimicrob Chemother 57:793–794PubMedCrossRef

13.

Johnson JR, Murray AC, Gajewski A, Sullivan M, Snippes P, Kuskowski MA, Smith KE (2003) Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother 47:2161–2168PubMedCrossRef

14.

Manfreda G, Cevoli C, Lucchi A, Pasquali F, Fabbri A, Franchini A (2010) Hot air treatment for surface decontamination of table eggs experimentally infected with Salmonella, Listeria, and Escherichia coli. Vet Res Commun 34(Suppl 1):S179–S182PubMedCrossRef

15.

Mesa RJ, Blanc V, Blanch AR, Cortes P, Gonzalez JJ, Lavilla S, Miro E, Muniesa M, Saco M, Tortola MT, Mirelis B, Coll P, Llagostera M, Prats G, Navarro F (2006) Extended-spectrum beta-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). J Antimicrob Chemother 58:211–215PubMedCrossRef

16.

Musgrove MT, Jones DR, Northcutt JK, Cox NA, Harrison MA (2004) Identification of Enterobacteriaceae from washed and unwashed commercial shell eggs. J Food Prot 67:2613–2616PubMed

17.

Oteo J, Navarro C, Cercenado E, Delgado-Iribarren A, Wilhelmi I, Orden B, Garcia C, Miguelanez S, Perez-Vazquez M, Garcia-Cobos S, Aracil B, Bautista V, Campos J (2006) Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol 44:2359–2366PubMedCrossRef

18.

Patterson PH, Ricke SC, Sunde ML, Schaefer DM (1990) Hatching eggs sanitized with chlorine dioxide foam: egg hatchability and bactericidal properties. Avian Dis 34:1–6PubMedCrossRef

19.

Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, Crellin J, Steward C, Hill B, Medeiros AA, Tenover FC (1997) Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 41:647–653PubMed

20.

Rodriguez-Romo LA, Yousef AE (2005) Inactivation of Salmonella enterica serovar Enteritidis on shell eggs by ozone and UV radiation. J Food Prot 68:711–717PubMed

21.

Sabate M, Tarrago R, Navarro F, Miro E, Verges C, Barbe J, Prats G (2000) Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrob Agents Chemother 44:1970–1973PubMedCrossRef

22.

Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Catry B, Herman L, Haesebrouck F, Butaye P (2008) Diversity of extended-spectrum beta-lactamases and class C beta-lactamases among cloacal Escherichia coli Isolates in Belgian broiler farms. Antimicrob Agents Chemother 52:1238–1243PubMedCrossRef

23.

Teshager T, Dominguez L, Moreno MA, Saenz Y, Torres C, Cardenosa S (2000) Isolation of an SHV-12 beta-lactamase-producing Escherichia coli strain from a dog with recurrent urinary tract infections. Antimicrob Agents Chemother 44:3483–3484PubMedCrossRef

24.

Warren RE, Ensor VM, O'Neill P, Butler V, Taylor J, Nye K, Harvey M, Livermore DM, Woodford N, Hawkey PM (2008) Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 61:504–508PubMedCrossRef

Title: Assessment of the presence of extended-spectrum beta-lactamase-producing Escherichia coli in eggshells and ready-to-eat products
Authors: P. Egea
L. López-Cerero
M. D. Navarro
J. Rodríguez-Baño
A. Pascual
Publication date: 01-09-2011
Publisher: Springer-Verlag
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2011
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-011-1168-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2011

Infant colonization by Staphylococcus aureus: role of maternal carriage

Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany

Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit

Evidence of circulation of an epidemic strain of Francisella tularensis in France by multispacer typing

Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study

Identification of immunogenic regions within the alternative reading frame protein of hepatitis C virus (genotype 3)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials